Larimar Therapeutics, Inc. (LRMR)
Across 21 earnings reports since May 10, 2021, Larimar Therapeutics, Inc. (LRMR) has a clear post-earnings pattern. It moves ±8.91% on average after reporting and finishes higher 47.6% of the time. Its largest post-earnings gain was +14.52% (Aug 14, 2025) and its largest decline was -36.28% (May 10, 2021). The next earnings report is predicted for 2026-08-10 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±8.91%
Positive %
47.6%
Negative %
52.4%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | ☀ PRE | $4.15 | $4.15 | $3.89 | 188,467 | -5.12% | open_in_new |
| Mar 19, 2026 | ☀ PRE | $4.27 | $4.67 | $4.47 | 2,445,300 | +3.95% | open_in_new |
| Nov 05, 2025 | ☀ PRE | $3.64 | $3.64 | $3.22 | 4,967,100 | -15.26% | open_in_new |
| Aug 14, 2025 | ☀ PRE | $3.71 | $4.33 | $4.26 | 2,586,800 | +14.52% | open_in_new |
| Apr 30, 2025 | ☀ PRE | $2.40 | $2.92 | $2.65 | 3,494,900 | +10.88% | open_in_new |
| Mar 24, 2025 | ☀ PRE | $2.60 | $2.61 | $2.28 | 1,374,500 | -10.24% | open_in_new |
| Oct 30, 2024 | ☀ PRE | $8.19 | $8.68 | $8.46 | 766,100 | +8.74% | open_in_new |
| Aug 07, 2024 | ☀ PRE | $7.73 | $7.73 | $7.15 | 441,900 | -6.54% | open_in_new |
| May 09, 2024 | ☀ PRE | $7.82 | $8.00 | $7.86 | 190,600 | -0.76% | open_in_new |
| Mar 14, 2024 | ☽ POST | $9.06 | $9.29 | $8.70 | 546,100 | +0.06% | open_in_new |
| Nov 14, 2023 | ☀ PRE | $2.40 | $2.79 | $2.56 | 176,800 | +7.11% | open_in_new |
| Aug 10, 2023 | ☀ PRE | $4.09 | $4.09 | $3.81 | 238,400 | -4.75% | open_in_new |
| May 15, 2023 | ☀ PRE | $4.03 | $4.31 | $3.59 | 2,184,100 | -29.05% | open_in_new |
| Mar 14, 2023 | ☀ PRE | $5.98 | $6.02 | $5.90 | 188,800 | +2.97% | open_in_new |
| Nov 10, 2022 | ☀ PRE | $3.01 | $3.14 | $3.07 | 32,400 | +3.72% | open_in_new |
| Aug 11, 2022 | ☽ POST | $2.02 | $2.02 | $1.98 | 1,437,800 | +7.07% | open_in_new |
| May 12, 2022 | ☀ PRE | $2.78 | $2.78 | $2.56 | 59,800 | -7.91% | open_in_new |
| Mar 25, 2022 | ☀ PRE | $4.10 | $4.10 | $3.94 | 39,400 | -0.76% | open_in_new |
| Nov 12, 2021 | ☀ PRE | $12.25 | $12.25 | $11.41 | 62,700 | -8.72% | open_in_new |
| Aug 12, 2021 | ☽ POST | $10.93 | $14.10 | $12.98 | 374,400 | +2.77% | open_in_new |
| May 10, 2021 | ☽ POST | $13.21 | $13.61 | $13.12 | 7,900 | -36.28% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±8.91%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 8-K | 20260519 | open_in_new SEC.gov |
| 10-Q | 20260514 | open_in_new SEC.gov |
| 8-K | 20260514 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260514 | open_in_new SEC.gov |
Frequently asked about LRMR earnings
When does Larimar Therapeutics, Inc. report earnings next? expand_more
Larimar Therapeutics, Inc. (LRMR)'s next earnings date is estimated for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does LRMR stock move after earnings? expand_more
Over 21 reports, LRMR has moved an average of ±8.91% the session after earnings, closing higher 47.6% of the time.
What was LRMR's biggest post-earnings move? expand_more
LRMR's largest post-earnings gain on record was +14.52% on Aug 14, 2025, and its largest decline was -36.28% on May 10, 2021.
Where can I find Larimar Therapeutics, Inc.'s SEC filings? expand_more
All of Larimar Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right